UCSF Health has opened the first-of-its-kind Inflammatory Bowel Disease (IBD) Longevity Clinic, designed exclusively for patients aged 65 and older living with IBD. Led by Dr. Kendall Beck and Dr. Anu Madhavan, the clinic brings together specialists in gastroenterology, geriatrics, pharmacy, and nutrition to deliver a truly multidisciplinary model of care. As the population ages, older adults are projected to become the majority of IBD patients within a decade. The UCSF clinic offers comprehensive assessments addressing mobility, cognition, bone health, medication management, and preventive care like cancer screenings and vaccinations.
Author: Abhay Panchal
Exact Sciences reported a record third quarter, underscoring its growing impact on early cancer detection. The company announced it helped more than 1.4 million people better understand and manage their cancer risk — a milestone reflecting its mission to eradicate cancer through prevention, early detection, and personalized treatment. Core revenue climbed 20% to $851 million, led by the continued success of Cologuard®, which reached record awareness levels this quarter with over 12,000 new providers ordering the test. Its oncology portfolio — including Oncotype DX® and the newly launched Cancerguard® multi-cancer early detection blood test — also saw strong global expansion.…
A new real-world study of 20,000 patients has found that Guardant Health’s Shield blood test achieved an impressive 95% adherence rate for colorectal cancer (CRC) screening — far higher than traditional colonoscopy or stool-based tests (25–71%). Published in Current Medical Research and Opinion, the findings reinforce Shield’s role as the first FDA-approved blood test for CRC screening in average-risk adults aged 45 and older. In an additional study from Appalachia, one of the nation’s lowest screening regions, overall screening rates doubled from 45% to 90% when Shield was introduced, with 98.5% adherence. By offering a simple blood draw instead of…
Dr. William D. Chey, a globally recognized expert in functional GI disorders, has been elected President of the American College of Gastroenterology (ACG) for 2025–2026. Currently the H. Marvin Pollard Professor of Gastroenterology at the University of Michigan and Chief of its GI Division, Dr. Chey brings over three decades of leadership, research, and mentorship to the role. A prolific innovator with 500+ publications and several patents, Dr. Chey is known for advancing the understanding of gut-brain interaction disorders and H. pylori infection. As ACG President, he will guide the College’s strategic priorities in education, policy, and clinical innovation, steering…
Artificial intelligence is rapidly transforming gastroenterology — from the endoscopy suite to the clinic. Experts highlight how AI models are moving beyond polyp detection to tackle some of the field’s toughest diagnostic challenges. Drs. Yuvaraj Singh, Alessandro Colletta, and Neil Marya showcased AI systems that outperform traditional ERCP sampling in identifying malignant biliary strictures and can even distinguish autoimmune pancreatitis from pancreatic cancer with higher accuracy than experts. These breakthroughs, trained on millions of images, promise faster, more reliable diagnoses in complex pancreatic and biliary disease. At a broader level, Dr. Dennis Shung discussed how foundation models like GastroNet-5M are…
A new endoscopic breakthrough at UT Health San Antonio is changing how colorectal lesions are treated. The center’s Advanced Interventional Gastroenterology Program has begun offering endoscopic submucosal dissection (ESD) — a minimally invasive procedure that removes large or early-stage colorectal lesions without surgery. Led by Dr. Matheus Franco, the first patient treated achieved a fully curative resection and went home the next day. Unlike traditional surgery, ESD allows complete lesion removal through a flexible scope, preserving bowel function and reducing recovery time.
Gastro Health, a leading national medical group specializing in digestive and liver health, finalized a partnership with Miami Gastro. The deal closed on November 1, 2025. Miami Gastro is the clinical practice of Danny J. Avalos, MD, who is board-certified in both gastroenterology and internal medicine. Dr. Avalos is highly active in the medical community and research, with a portfolio of over 40 peer-reviewed articles focused on colon cancer prevention, hepatitis C eradication, inflammatory bowel diseases, and motility disorders. The office also offers advanced on-site imaging services, including capsule endoscopy and FibroScan.
A growing shortage of anesthesia professionals is forcing gastroenterologists to reconsider how sedation is delivered in endoscopy. At ACG 2025, a national survey revealed that while only 4% of GIs currently perform endoscopist-directed moderate sedation, most want more training—particularly in safely administering propofol. Experts, led by Dr. Dayna Early of Washington University, warned that limited fellowship exposure and overreliance on CRNAs could restrict procedure access, especially in rural areas. With 450,000 CRNA shortages projected this year and new agents like remimazolam showing promise as safer alternatives, many believe it’s time for gastroenterologists to reclaim sedation from anesthesia teams—but only with…
A randomized trial led by researchers at the University of Pennsylvania Health System has shown that simple behavioral nudges—such as text message reminders and mailed letters—significantly improve participation in mailed colorectal cancer (CRC) screening programs. The pragmatic study, published in Clinical Gastroenterology and Hepatology, enrolled 5,244 adults aged 50–74 who were overdue for CRC screening. Participants were mailed fecal immunochemical test (FIT) kits and randomly assigned to different outreach strategies: Key Findings Why It Matters The findings underscore that low-cost, behaviorally informed communication—like text nudges and mailed letters—can drive meaningful improvements in preventive screening uptake.Fancy packaging, however, adds cost without…
Together with 20 physician specialty organizations, AGA sent a letter to the Center for Consumer Information and Insurance Oversight to increase oversight of health plans that are automatically “down-coding” evaluation and management (E/M) claims. Several insurers, including Aetna, Cigna, Anthem, and Humana, have adopted systems that automatically adjust E/M CPT code levels based on time and complexity.